Statistics for Iterum Therapeutics plc (id:6128 ITRM)

Valuation metrics

Market cap

44.85M

Enterprise value

40.78M

Trailing P/E (ttm)

-0.66

Forward P/E

-2.47

PEG ratio

-2.47

Price/Sales (ttm)

Price/Book (mrq)

-3.15

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.09

Overview

Shares outstanding

27.52M

Float

21.96M

Shares short

2.53M

% Held by insiders

0.02%

% Held by institutions

0.09%

Average volume (10 days)

1.06M

Average volume (90 days)

Price summary

52-Week low

0.81

52-Week high

2.50

52-Week change

-27.07%

Beta

2.25

50-Day moving average

1.16

200-Day moving average

1.33

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 18th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-73.35%

Return on equity

599.27%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-37,364,000.00

Net income to common (ttm)

-28,337,000.00

Diluted EPS (ttm)

-1.76

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

11.72M

Total cash per share (mrq)

0.52

Total debt (mrq)

21.62M

Total Debt/Equity (mrq)

-1.88

Current ratio (mrq)

81.60%

Book value per share (mrq)

-0.47

Cash flow

Cash flow statement

-41,950,000.00

Levered free cash flow (LFCF)

-28,464,500.00